Carvedilol and Cardiac Biomarkers in Dialysis Patients: Secondary Analysis of a Randomized Controlled Trial

• Main Authors: Matthew A. Roberts (Author), Darsy Darssan (Author), Sunil V. Badve (Author), Robert P. Carroll (Author), Magid A. Fahim (Author), Brian A. Haluska (Author), Carmel M. Hawley (Author), Nicole M. Isbel (Author), Mark R. Marshall (Author), Elaine M. Pascoe (Author), Eugenie Pedagogos (Author), Helen L. Pilmore (Author), Paul Snelling (Author), Tony Stanton (Author), Ken-Soon Tan (Author), Andrew M. Tonkin (Author), Liza A. Vergara (Author), Francesco L. Ierino (Author)
• Format: Book
• Published: Karger Publishers, 2017-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background/Aims: Cardiac biomarkers are associated with cardiac abnormalities and adverse outcomes in dialysis patients. Our aim was to report the effect of the beta-blocker carvedilol on cardiac biomarkers in adult dialysis patients. Methods: The Beta-Blocker to Lower Cardiovascular Dialysis Events...